Medicines labeled for the same conditions
Alternatives to fosinopril and hydrochlorothiazide
56 other medicines are given the same way (oral) and in the same FDA class as fosinopril and hydrochlorothiazide or labeled mainly for the same use (high blood pressure); 11 are in its class, angiotensin converting enzyme inhibitors: lisinopril, enalapril, amlodipine and benazepril, benazepril and 7 more; the others include 9 beta-adrenergic blockers, 7 angiotensin 2 receptor blockers and 6 calcium channel blockers (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.0254 per lisinopril 20 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as fosinopril and hydrochlorothiazide?
The first 24 of the 56, the same class first. High blood pressure lists all 88 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Fosinopril and hydrochlorothiazideangiotensin converting enzyme inhibitor | this medicine | 2 labelers | $0.634 per tablet 10-12.5 mg tablet | Yes | No current entry |
| Lisinoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 36 labelers | $0.0254 per tablet 20 mg tablet | Yes | No current entry |
| Enalaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 29 labelers | $0.0664 per tablet 10 mg tablet | Yes | No current entry |
| Amlodipine and benazeprilcalcium channel blocker · same class | High blood pressure | 16 labelers | $0.114 per unit 10-20 mg | Yes | No current entry |
| Benazeprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 21 labelers | $0.0789 per tablet 20 mg tablet | Yes | No current entry |
| Ramiprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 17 labelers | $0.0707 per capsule 10 mg capsule | Yes | No current entry |
| Captoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 13 labelers | $0.228 per tablet 12.5 mg tablet | Yes | No current entry |
| Quinaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 9 labelers | n/a | Yes | In shortage |
| Trandolaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 5 labelers | $0.157 per tablet 1 mg tablet | Yes | No current entry |
| Trandolapril and verapamilcalcium channel blocker · same class | High blood pressure | 1 labeler | n/a | Yes | No current entry |
| Perindoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 1 labeler | $0.495 per tablet 4 mg tablet | Yes | No current entry |
| Chlorothiazidethiazide diuretic · same class | High blood pressure | none listed | n/a | No | A presentation being discontinued |
| Metoprololbeta-adrenergic blocker | High blood pressure | 64 labelers | $0.085 per tablet 100 mg tablet | No | A presentation being discontinued |
| Diltiazemcalcium channel blocker | High blood pressure | 42 labelers | $0.144 per capsule 24h ER(cd) 120 mg capsule | No | A presentation being discontinued |
| Propranololbeta-adrenergic blocker | High blood pressure | 38 labelers | $0.0493 per tablet 20 mg tablet | No | In shortage |
| Losartanangiotensin 2 receptor blocker | High blood pressure | 44 labelers | $0.0327 per tablet 50 mg tablet | Yes | No current entry |
| Amlodipinecalcium channel blocker | High blood pressure | 42 labelers | $0.0102 per tablet 5 mg tablet | No | No current entry |
| Clonidinecentral alpha-2 adrenergic agonist | High blood pressure | 37 labelers | $0.0241 per tablet 0.1 mg tablet | No | No current entry |
| Valsartanangiotensin 2 receptor blocker | High blood pressure | 34 labelers | $0.0963 per tablet 40 mg tablet | Yes | A presentation being discontinued |
| Nifedipinedihydropyridine calcium channel blocker | High blood pressure | 32 labelers | $0.130 per tablet 30 mg tablet | No | No current entry |
| Atenololbeta-adrenergic blocker | High blood pressure | 35 labelers | $0.0217 per tablet 25 mg tablet | No | No current entry |
| Olmesartanangiotensin 2 receptor blocker | High blood pressure | 31 labelers | $0.0805 per tablet 20 mg tablet | Yes | No current entry |
| Labetalolbeta-adrenergic blocker | High blood pressure | 31 labelers | $0.215 per tablet 300 mg tablet | No | No current entry |
| Prazosinalpha-adrenergic blocker | High blood pressure | 33 labelers | $0.0842 per capsule 1 mg capsule | No | A presentation being discontinued |
| Chlorthalidonethiazide-like diuretic | High blood pressure | 36 labelers | $0.0743 per tablet 25 mg tablet | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Fosinopril and hydrochlorothiazide: the full record
- label, generics, price, shortages, recalls